[Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
D000632:Aminopyrine / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D006801:Humans; D010653:Phenylbutazone / Q000627:therapeutic use*; D011720:Pyrazoles; D047069:Pyrazolones
D000632:Aminopyrine; D001713:Biphenyl Compounds; D010653:Phenylbutazone; D011720:Pyrazoles; D047069:Pyrazolones; C010574:biphenyl; C031280:pyrazole
AMINOPYRINE/therapeutic use; PHENYLBUTAZONE/therapeutic use
Die Behandlung interner Erkrankungen mit 3, 5-Dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidin und der Kombination dieser Substanz mit Dimethylaminophenyldimethylpyrazolon.